Flathead National Forest officials answered questions Thursday night in a roundtable discussion about a special use permit ...

The Flathead National Forest Service held a community meeting to discuss a special use permit for potential buyers of Holland ...

The 5,000-square foot lodge at Lapham Peak has a large gathering area with a fireplace, multipurpose room and a covered patio ...

The Flamingo Lodge, in Florida's Everglades National Park, was completely rebuilt and recently reopened after nearly 20 years ...

A historic lodge where a famous U.S. President stayed is set in the heart of an ancient forest in the Olympic Peninsula of ...

Forest ecology is the study of all aspects of the ecology of wooded areas, including rainforest, deciduous and evergreen, temperate and boreal forest. It includes the community ecology of the ...

Merck licenses the protein, called berahyaluronidase alfa, from Alteogen. Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents.

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma) for the latter’s investigational oral small-molecule ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, the US drugmaker’s second recent foray into China for a novel medicine.

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the latest in a series of cross-border deals between Western ...